The mRNA-based BNT162b2 vaccine from Pfizer/BioNTech was the first registered COVID-19 vaccine and has been shown to be up to 95% effective in preventing SARS-CoV-2 infections. Little is known about the broad effects of the new class of mRNA vaccines, especially whether they have combined effects on innate and adaptive immune responses. Here we confirmed that BNT162b2 vaccination of healthy individuals induced effective humoral and cellular immunity against several SARS-CoV-2 variants. Intere...| medRxiv
Recent epidemiological studies have shown that, in addition to disease-specific effects, vaccines against infectious diseases have nonspecific effects on the ability of the immune system to handle other pathogens. For instance, in randomized trials tuberculosis and measles vaccines are associated wi …| PubMed
To examine the possible non-specific effects (NSEs) of the novel COVID-19 vaccines, we reviewed the randomised control trials (RCTs) of mRNA and adenovirus-vect| papers.ssrn.com
Darf ich Sie mit altem Wissen langweilen? Wenn ich gewisse Zeitungsartikel lese, scheint mir, eine Wiederholung von Altbekanntem sei angebracht. Seit vielen Jahren wissen wir, wie […]| corona-elefant.ch
Es ist auffällig, dass im Zusammenhang mit Covid-19 sowohl in den Medien wie auch in der Fachliteratur immer wieder das erworbene Immunsystem mit seinen Antikörpern und […]| corona-elefant.ch
